Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hepatic T1-Time Predicts Cardiovascular Risk in All-Comers Referred for Cardiovascular Magnetic Resonance: A Post-Hoc Analysis.
Mascherbauer K, Donà C, Koschutnik M, Dannenberg V, Nitsche C, Duca F, Heitzinger G, Halavina K, Steinacher E, Kronberger C, Bardach C, Beitzke D, Loewe C, Waldmann E, Trauner M, Barkto P, Goliasch G, Mascherbauer J, Hengstenberg C, Kammerlander A. Mascherbauer K, et al. Among authors: steinacher e. Circ Cardiovasc Imaging. 2022 Oct;15(10):e014716. doi: 10.1161/CIRCIMAGING.122.014716. Epub 2022 Oct 18. Circ Cardiovasc Imaging. 2022. PMID: 36256728
Relationship of Fibroblast Growth Factor 23 With Hospitalization for Heart Failure and Cardiovascular Outcomes in Patients Undergoing Cardiac Surgery.
Hofer F, Hammer A, Pailer U, Koller L, Kazem N, Steinacher E, Steinlechner B, Andreas M, Laufer G, Wojta J, Zelniker TA, Hengstenberg C, Niessner A, Sulzgruber P. Hofer F, et al. Among authors: steinacher e. J Am Heart Assoc. 2023 Mar 7;12(5):e027875. doi: 10.1161/JAHA.122.027875. Epub 2023 Feb 21. J Am Heart Assoc. 2023. PMID: 36802737 Free PMC article.
Prescribing trends of sodium-glucose cotransporter 2 inhibitors in patients with heart failure with preserved, mildly reduced and reduced ejection fraction.
Hofer F, Hammer A, Steinacher E, Baumer U, Kazem N, Koller L, Richter B, Hengstenberg C, Sulzgruber P, Niessner A. Hofer F, et al. Among authors: steinacher e. Eur Heart J Cardiovasc Pharmacother. 2023 Sep 20;9(6):505-506. doi: 10.1093/ehjcvp/pvad022. Eur Heart J Cardiovasc Pharmacother. 2023. PMID: 36963781 No abstract available.
The Impact of Preclinical High Potent P2Y12 Inhibitors on Decision Making at Discharge and Clinical Outcomes in Patients with Acute Coronary Syndrome.
Hammer A, Krammel M, Aigner P, Pfenneberger G, Schnaubelt S, Hofer F, Kazem N, Koller L, Steinacher E, Baumer U, Hengstenberg C, Niessner A, Sulzgruber P. Hammer A, et al. Among authors: steinacher e. J Clin Med. 2023 Jun 16;12(12):4094. doi: 10.3390/jcm12124094. J Clin Med. 2023. PMID: 37373788 Free PMC article.
Sex-Related Disparities in Prescription Patterns of Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Type 2 Diabetes and Heart Failure.
Hammer A, Hofer F, Kazem N, Koller L, Steinacher E, Baumer U, Wollmann F, Kautzky-Willer A, Beitl K, Remer F, Hengstenberg C, Niessner A, Sulzgruber P. Hammer A, et al. Among authors: steinacher e. J Womens Health (Larchmt). 2023 Nov;32(11):1219-1228. doi: 10.1089/jwh.2023.0059. Epub 2023 Aug 28. J Womens Health (Larchmt). 2023. PMID: 37638826
Bifurcation-Lesion PCI Guided by OCT or Angiography.
Steinacher E, Koller L, Niessner A. Steinacher E, et al. N Engl J Med. 2024 Jan 11;390(2):187-188. doi: 10.1056/NEJMc2313258. N Engl J Med. 2024. PMID: 38197829 No abstract available.
11 results